Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 3Phase 1 2Phase NA 1Phase 4 1

Status

Completed 15Recruiting 9Unknown 6Active not recruiting 6Withdrawn 4Terminated 3Not yet recruiting 3

Sponsor Class

OTHER 9

Study Type

Interventional 9

Sponsor

Cancer Type

Breast 8Gynecologic 1

Conditions

Breast Neoplasms 5Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer 1HR+/HER2- Early Breast Cancer 1HR+/HER2+ Early Breast Cancer 1Endometrial Stromal Tumors 1

Interventions

pembrolizumab 219Carboplatin 218Specimen Handling 198Cisplatin 188Magnetic Resonance Spectroscopy 168Radiotherapy 152Bevacizumab 142Gemcitabine 135Cyclophosphamide 133Drug Therapy 118Capecitabine 118Paclitaxel 112Oxaliplatin 110Biopsy 107venetoclax 102Nivolumab 101Rituximab 83tislelizumab 81durvalumab 81toripalimab 77Fluorouracil 73Etoposide 72Dexamethasone 70sintilimab 67Radiosurgery 67Docetaxel 67Pemetrexed 65atezolizumab 64Azacitidine 63Injections 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

9 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Aromatase Inhibitors × Clear all
NCT07616427 2026-06-01

TAYLOR-003

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Recruiting
100 enrolled
Breast

HR+/HER2+ Early Breast Cancer

NCT07616453 2026-06-01

TAYLOR-002

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Recruiting
45 enrolled
Breast

HR+/HER2- Early Breast Cancer

NCT03624244 2026-02-17

BFR-ESS

Centre Leon Berard

Phase 2 Recruiting
40 enrolled
Gynecologic

Endometrial Stromal Tumors

NCT06970912 2026-01-21

DNADalHR

Peking University People's Hospital

Phase 2 Recruiting
393 enrolled
Breast

Breast Neoplasms

NCT06107673 2025-12-11

Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer (EBC)

Hebei Medical University Fourth Hospital

Phase 2 Recruiting
144 enrolled
Breast

Breast Neoplasms

NCT06361940 2025-10-14

MAPPER

Medical College of Wisconsin

Phase 2 Recruiting
100 enrolled
Breast

Breast Neoplasms

NCT05190094 2025-05-07

ICRG0201

International Cancer Research Group, United Arab Emirates

Phase 2 Recruiting
80 enrolled
Breast

Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer

NCT05594095 2024-10-04

SNF Platform Study of HR+/ HER2-advanced Breast Cancer

Fudan University

Phase 2 Recruiting
620 enrolled
Breast

Breast Neoplasms

NCT05949541 2024-02-08

BCTOP-L-M01

Fudan University

Phase 2 Recruiting
265 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡